Greenwich LifeSciences (GLSI)
(Delayed Data from NSDQ)
$19.94 USD
-0.06 (-0.30%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $19.94 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/29/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.19 |
Last EPS Surprise | 13.64% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.68 |
Next Year | -0.76 |
EPS (TTM) | -0.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.20 | -0.68 | -0.76 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.20 | -0.20 | -0.68 | -0.76 |
High Estimate | -0.20 | -0.20 | -0.68 | -0.76 |
Low Estimate | -0.20 | -0.20 | -0.68 | -0.76 |
Year ago EPS | -0.22 | -0.17 | -0.61 | -0.68 |
Year over Year Growth Est. | 9.09% | -17.65% | -11.48% | -11.76% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | -0.20 | -0.20 | -0.68 | -0.76 |
7 Days Ago | -0.20 | -0.20 | -0.68 | -0.76 |
30 Days Ago | -0.20 | NA | -0.68 | -0.76 |
60 Days Ago | -0.22 | NA | -0.89 | NA |
90 Days Ago | -0.22 | NA | -0.89 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.20 | -0.68 | -0.76 |
Zacks Consensus Estimate | -0.20 | -0.20 | -0.68 | -0.76 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.19 | -0.13 | -0.17 | -0.22 | NA |
Estimate | -0.22 | -0.23 | -0.23 | NA | NA |
Difference | 0.03 | 0.10 | 0.06 | NA | 0.06 |
Surprise | 13.64% | 43.48% | 26.09% | NA | 27.74% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more